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tomical success but a similar number of adverse effects were 
observed with heavy silicone oil in vitreous. Nevertheless, 
patients who received Densiron 68 twice due to redetach-
ment showed a significantly higher rate of intraocular in-
flammation with the tamponade agent in situ.  Conclusion: 
Our results support the hypothesis of Densiron 68 as potent 
tamponade agent for complicated retinal detachment in the 
inferior retinal segments especially in eyes where a previous 
operation failed. 
 
Copyright © 2007 S. Karger AG, Basel 
 Introduction 
 The well-established tamponade agents such as sili-
cone oil or gas provide good support in cases of compli-
cated retinal detachment. Nevertheless, the results in 
eyes where pathology is located inferiorly, especially in 
the presence of proliferative vitreoretinopathy (PVR) that 
has a propensity to occur in the inferior retina, are still 
dissatisfactory  [1–4] . Other substances, for example per-
fluorocarbon liquids, that are able to sink due to their 
high specific gravity can only be used intraoperatively or 
for short-term application because of their retinotoxicity, 
increased postoperative inflammation reactions and dis-
persion  [5–10] . The search for a biocompatible heavy 
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 Abstract 
 Background: High-density silicone oils are newly developed 
long-term tamponade agents for the treatment of compli-
cated retinal detachment in the inferior retina. Previous 
studies describe satisfying anatomical and functional re-
sults. In this study we examined the largest cohort so far for 
a 9-month follow-up and performed a comparison to con-
ventional silicone oil.  Methods: Our study documents re-
sults and adverse effects after vitreoretinal surgery and en-
dotamponade with Densiron  68 in 99 cases of complicated 
retinal detachment. A 9-month follow-up was performed. 
Data of 21 patients with intraocular conventional silicone oil 
tamponade in complicated retinal detachment were retro-
spectively analyzed and served as control.  Results: Anatom-
ical success was achieved in 78 of 89 eyes (87.6%) with com-
pleted follow-up; visual acuity did not change significant-
ly (from mean preoperative logMAR 1.88 to postoperative 
logMAR 1.96 (p = 0.9). Compared to control a higher ana-
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long-term tamponade led to the development of mixtures 
of semifluorinated alcanes and silicone oil, so-called 
heavy silicone oils  [11, 12] . Densiron  68 (Geuder AG, 
Neu-Ulm, Germany), a mixture of perfluorohexyloctane 
(F 6 H 8 ) and polydimethylsiloxane with a specific density 
of 1.06 g/cm 3  fulfills this profile and is available for the 
treatment of inferior or posterior retinal detachment in 
cases of PVR, proliferative diabetic retinopathy or giant 
retinal tears. Wong et al. [13] described 42 patients with 
Densiron 68 treatment. They achieved an anatomical 
success rate of 93% including all necessary reoperations. 
Clinically significant dispersion or inflammatory reac-
tions were not observed  [13] . Recently we reported our 
experiences with Densiron 68 as intraocular tamponade 
in 48 eyes. That report focused on results of a 3-month 
follow-up in patients with previously unsuccessful retinal 
detachment surgery  [14] . The initial anatomical success 
rate was 45.8% and increased to 91.7% (44/48 eyes) with 
further interventions. Now we describe the so far largest 
study population (99 cases) with complicated inferior ret-
inal detachment and heavy silicone oil treatment. To ex-
amine whether the short-term results that had been pub-
lished recently by us show a stable course and whether 
late adverse effects may occur, we included these data in 
the here presented study but prolonged the observation 
period up to 9 months. In addition, eyes without any pre-
ceding operation on the posterior eye, cases with a second 
heavy oil tamponade and a historical control group with 
conventional silicone oil (polydimethylsiloxane, 5000cs) 
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 Fig. 1. Overall view of patient numbers and 
groups. 




 Study Design and Subjects 
 This prospective interventional case study includes all 99 eyes 
that had an indication for the treatment with high-density sili-
cone oil and received intraocular Densiron 68 tamponade be-
tween October 2003 and December 2004 in our department 
( fig. 1 ). Additionally data of 21 patients with inferior or posterior 
complicated retinal detachment that had been operated for the 
first time on the posterior eye and had got conventional silicone 
oil (5000cs) as intraocular tamponade recently before Densiron 
68 tamponade was established in our department (between April 
and October 2003) were retrospectively analyzed. All series were 
performed by the same surgeon (K.E.). The patients were in-
formed about the new character of Densiron 68.
 Intervention 
 The surgical procedures of the vitrectomy, Densiron 68 injec-
tion and its removal 3 months later were carried out as recently 
described by us  [14] .  A standard 3-port pars plana vitrectomy was 
performed; membrane peeling, retinotomies or relaxing retinec-
tomies were added if necessary. Thereafter, Densiron 68 was in-
stilled as endotamponade. The removal was planned 3 months 
after instillation. 
 Postoperative Procedure/Follow-up 
 All patients were controlled on day 1 and 6 weeks, 3 months 
and 6 months after the Densiron 68 removal. At each control the 
patients underwent the examination of visual acuity, Goldmann 
applanation tonometry and slit lamp biomicroscopy with indirect 
ophthalmoscopy. All unscheduled appointments, complications 
or additional interventions were documented. 
 Group Formation 
 To enable an interpretation of the data depending on the case 
history we separated the cases in three main groups: group 1 in-
cludes 21 patients with retinal detachment in the inferior circum-
ference without surgical retinal interventions before heavy sili-
cone oil tamponade; group 2 consists of 5 patients who received 
heavy silicone oil twice because of retinal redetachment in the 
inferior or central parts of the retina; group 3 contains patients 
with retinal redetachment who received heavy silicone oil after 
previous retinal surgery had failed (n = 73). The 21 patients with 
primary conventional silicone oil treatment are summarized in 









Age, years 60 (13–85) 73 (63–84) 65 (17–82) 64 (13–85)
Diagnosis
Retinal detachment 21 21
Retinal redetachment 3 33 36
Persisting detachment/redetachment with
intraocular tamponade 2 39 41
Retinal detachment and AMD 1 1
Primary pseudophakic retinal detachment 3 1 16 20
Primary traumatic retinal detachment 7 7











Total 7 14 21
Central 1 2 1 4
Inferior and central 3 3
PVR grading
None 3 1 15 19
B 1 1
<CA3/<CP3 1/5 1/2 4/23 6/30
CA3–CA5/CP3–CP5 1/6 0/1 3/18 4/25
>CA5/>CP5 3/2 0/0 3/6 6/8
High myopia (>–7 dpt) 4 1 7 12
PDR 5 0 8 13
Glaucoma 2 0 10 12
Figures in parentheses indicate ranges. AMD = Age-dependent macular degeneration; PDR = proliferative 
diabetic retinopathy. Group 1: patients without previous retinal surgery; group 2: patients with repeated Den-
siron 68 tamponade; group 3: patients with previous retinal detachment surgery.
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group 4 and served as control to group 1. Both, group 1 and group 
4, are comparable in age, localization of retinal detachment and 
preexisting ophthalmological diseases such as PVR, proliferative 
diabetic retinopathy, high myopia and glaucoma. For description 
of PVR the modified classification of Machemer et al. [15] was 
used. High myopia was defined as myopia more than –7 dpt.  
 The preoperative data of the study population are given in  ta-
bles 1 and  2 . 
 Definition of Anatomical Success and Complications 
 Anatomical success was achieved when the retina was re-
attached completely or only a stable peripheral redetachment 
(posterior to the encircling band, if extant) occurred. Elevated 
intraocular pressure (IOP) was defined as pressure  1 21 mm 
Hg, hypotony as an IOP  ! 5 mm Hg. Keratopathy includes bul-
lous or band keratopathy, stromal edema or circumscribed opac-
ities. 
 Statistical Analysis 
 Data were analyzed using SPSS 11.0 for Windows. Compari-
sons of binomial proportions were calculated using Fisher’s exact 
test. Group differences were calculated by ANOVA. Variables 
were checked for normal distribution using the Kolmogorov-










Phakic 10 0 8 18
Aphakic 1 0 5 6
Pseudophakic 10 5 60 75
Previous surgical interventions in the
posterior segment 0 2.0 2.0 1.6
Previous scleral buckling surgery 0 2 46 48
Previous standard silicone oil tamponade 0 3 51 54
Group 1: patients without previous retinal surgery; group 2: patients with repeated 
Densiron 68 tamponade; group 3: patients with previous retinal detachment surgery.
Table 2. Summarized preoperative 
surgical interventions of the entire study 
population









Reattachment rate 15 (71) 3 (60) 54 (74) 72 (73)
Retinal redetachment 6 2 19 27
Inferior 2 10
Superior 1 1 6
Central 2 1 2
Total 1 1
Complications
None 2 (9.5) 0 23 (31.5) 25
Emulsified oil, corneal and lenticular bloom 8 (38.1) 2 (40) 21 (28.8) 31
Raised IOP 5 (23.8) 0 15 (20.5) 20
Inflammation 5 (23.8) 4 (80) 8 (11) 17
New membrane formation 3 (14.3) 0 7 (9.6) 10
Keratopathy 2 (9.5) 1 (20) 1 (1.4) 4
Hypotony 1 (4.7) 0 0 1
Figures in parentheses indicate percentages. Raised IOP (>21 mm Hg) = temporary or chronic elevated IOP; 
new membrane formation = new sub- and epiretinal membrane formation; keratopathy = temporary or chron-
ic corneal affection; hypotony = temporary or chronic hypotony. Group 1: patients without previous retinal 
surgery; group 2: patients with repeated Densiron 68 tamponade; group 3: patients with previous retinal de-
tachment surgery.
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deviation of variables during follow-up, a two-tailed paired t test 
was performed. Statistical significance was considered to be pres-
ent at the 5% level.
 Results 
 The Densiron endotamponade was removed in 93 cas-
es after a mean time of 96 days (range 8–351). Eighty-nine 
patients completed the 6-month follow-up after oil re-
moval. Two patients rejected the oil removal for personal 
reasons, 1 patient with a visual acuity of no light percep-
tion rejected the oil removal because of the bad prognosis, 
3 patients died before removal of non-tamponade-associ-
ated reasons. The dropout of 4 other patients after oil re-
moval was due to personal reasons.
 Anatomical Results during Intraocular Oil 
Tamponade 
 At surgery complete reattachment was achieved in 97 
of 99 cases. In 1 eye with severe traumatic destruction of 
the eye and in another with PVR grade CA12 and mul-
tiple preoperation, the trial of intraoperative reattach-
ment failed. During Densiron 68 tamponade, a retinal 
redetachment occurred in 27 eyes. 
 The results and adverse effects subdivided into the 
three groups are shown in  table 3  and  figure 2 .
 Comparison of Eyes with Primary Heavy Silicone Oil 
Tamponade to Control 
 Anatomical success was achieved in 15 of 21 eyes (71%) 
with heavy silicone oil in situ and in 9 of 21 eyes (53%) 
with conventional silicone oil treatment. This difference 
is not significant. The distribution of the localization of 
retinal redetachment shows a high rate of renewed infe-
rior detachment in eyes with conventional silicone oil in 
vitreous (8 of 12 eyes). As it is shown in  table 4 , the com-
plication rate does not differ significantly between group 
1 and group 4.
 Anatomical Results after Removal of Densiron 68 
 The following analysis includes the 89 of initially 99 
cases that completed the 6-month follow-up after the 
Densiron 68 had been removed.
 Retinal Reattachment 
 Immediately after Densiron removal the retina was at-
tached in 82 of the 89 eyes that completed the follow-up 
(92%). During the follow-up the retina stayed attached in 
57/89 eyes (64%). Single redetachment occurred in 28/89 
eyes, 4/89 eyes showed recurrent retinal detachment. An 
average of 1.62 reoperations on the posterior eye was per-
formed. This number includes heavy silicone oil removal 
because additional retinal manipulations were performed 
simultaneously in some cases to achieve or to stabilize 
retinal reattachment. Further surgeries involved conven-
tional silicone oil, second heavy oil or gas tamponade. 
Nine months after initial surgery, anatomical success was 
achieved in 78 eyes (87.6%), of which 50 (56.2%) showed 
a completely attached retina without any tamponade 
agent in situ. In 1 eye the retinal situation could not be 
estimated due to recurrent vitreous hemorrhage. In 45 of 
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 Densiron 68 removal      
 Fig. 2. Anatomical results (89 of 99 patients with completed fol-
low-up). 
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gery occurred, in 24 of them previous treatment with 
conventional oil tamponade had failed. In all eyes with a 
second heavy oil tamponade (group 2) the retina was 
completely reattached. These results are summarized in 
 table 5 . 
 In 19 cases new retinal breaks developed during the 
observation period. In these eyes the proportion of reti-
nal redetachment was highest (p = 0.001). At study end 
point, anatomical failure was due to reproliferation pro-
cesses with sub- and intraretinal fibrosis in 7 eyes, forma-
tion of new retinal breaks (2 eyes) or both (1 eye). 
 New Membrane Formation 
 New sub- and epiretinal membrane formation occurred 
in 10 eyes (9 with preexisting PVR) during intraocular oil 
tamponade and in 33 eyes (29 with preexisting PVR) after 
oil removal. The rate of new membrane development was 
significantly elevated in eyes with preexisting PVR (p  ! 
0.05) and proliferative diabetic retinopathy (p  ! 0.01). 
 Emulsified Oil 
 After heavy oil injection the oil was found in the ante-
rior chamber in 29 eyes; 14 of them showed emulsifica-
tion droplets or pseudohypopyon. At the final control 12 
Group 1
(heavy silicone oil
tamponade, n = 21)
Group 4










Localization of retinal detachment
Inferior 4 3
Inferior and superior 9 8
Total 7 6
Central 1 2
Inferior and central 0 2
Preoperative visual acuity 2.7781.32 2.8681.29 p = 0.82
Postoperative visual acuity 2.3681.23 1.8481.04 p = 0.15
Significance of changes p = 0.125 p < 0.0001
Persisting detachment/






Raised IOP 5 5






New membrane formation 3 3
Keratopathy 2 2
Hypotony 1 0
PDR = Proliferative diabetic retinopathy. Raised IOP (>21 mm Hg) = temporary or 
chronic elevated IOP; new membrane formation = new sub- and epiretinal membrane 
formation; keratopathy = temporary or chronic corneal affection; hypotony = temporary 
or chronic hypotony.
1 Temporary moderate postoperative inflammation.
2 Preexisting chronic intermedial uveitis.
3 Epidemic keratoconjunctivitis.
Table 4. Comparison of group 1 with 
group 4 during 3 months of intraocular 
heavy or standard silicone oil tamponade
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out of 50 eyes without any tamponade agent in vitro 
showed remaining tiny oil droplets in the anterior cham-
ber. Significant emulsification on the epiretinal surface 
could not be found.
 Functional Results after Removal of Densiron 68 
 Visual acuity did not change significantly from preop-
erative mean logMAR 1.88  8 1.15 to 1.96  8 1.24 nine 
months later (p = 0.9). Ambulatory vision of 1/50 
(20/1,000) or better could be preserved in 55 eyes (61%). 
In anatomically successful cases without tamponade 
agent in vitreous at study end point, visual acuity was sig-
nificantly higher (mean logMAR 1.53) than in eyes with 
retinal reattachment but silicone oil left in situ (mean
logMAR 2.21) or in eyes that showed retinal redetach-
ment (mean logMAR = 3.20; p  ! 0.0001). In 33 of 89 eyes 
(37%) an improvement of 2 Snellen lines could be 
achieved. 
 Complications  
 Raised IOP 
 With heavy silicone oil in vitreous 20 eyes developed 
raised IOP, 4 of them with preexisting glaucoma. The rate 
of temporarily raised IOP in patients with silicone oil in 
the anterior chamber was significantly higher than in 
those without (p = 0.04). After removal of heavy oil IOP 
normalized in 9 eyes; 13 further patients developed tem-
porarily raised IOP. Secondary glaucoma occurred in 7 
eyes with multiple preoperation (group 3). Mean IOP af-
ter oil removal was 13.1  8 5.8 mm Hg. It remained con-
stant throughout the observation period without signifi-
cant differences between the three groups. 
 Intraocular Inflammation 
 A mild to moderate inflammatory activity of the an-
terior segment during Densiron 68 tamponade was ob-
served in 13/99 eyes. Four eyes developed a severe intra-
Table 5. Results and complications after removal of Densiron 68
Group 1 (n = 19) Group 2 (n = 5) Group 3 (n = 65) All (n = 89)
Duration of heavy tamponade, days 85 (33–126) 70 (29–108) 104 (8–400) 95 (8–351)
Number of reoperations on the posterior eye 1.53 (1–3) 1.8 (1–3) 1.63 (1–4) 1.62 (1–4)
Number of repeated intraocular tamponade 0.74 (0–2) 0.8 (0–2) 0.71 (0–2) 0.71 (0–2)
Anatomical situation 6 months after removal of heavy oil: 
reattachment
Without intraocular tamponade 8 3 39 50
Standard silicone oil in vitreous 5 2 20 27
With heavy silicone oil in vitreous 0 0 1 1
Number of anatomically successful cases 13 (68.4%) 5 (100%) 60 (92.3%) 78 (87.6%)
Retinal redetachment 5 (26%) 0 5 (7.7%) 10 (11.2%)
Superior 1 1
Central 3 3 6
Total 1 2 3
Visual acuity
Preoperative mean logMAR 2.6481.32 1.6881.02 1.6881.03 1.8881.15
Postoperative mean logMAR 2.2081.45 1.5780.81 1.9281.21 1.9681.24
Significance of changes p = 0.17 p = 0.78 p = 0.13 p = 0.9
Complications 
None 4 0 9 13
Emulsified oil, corneal and lenticular bloom 9 5 44 58
New membrane formation 6 4 23 33
Redetachment during follow-up 8 1 23 32
Raised IOP 5 1 18 24
Inflammation 7 1 11 19
Keratopathy 6 1 10 17
Hypotony 3 1 10 14
Figures in parentheses are ranges, or percentages where indicated. Raised IOP (>21 mm Hg) = temporary or chronic elevated IOP; 
new membrane formation = new sub- and epiretinal membrane formation; keratopathy = temporary or chronic corneal affection; 
hypotony = temporary or chronic hypotony. Group 1: patients without previous retinal surgery; group 2: patients with repeated Den-
siron 68 tamponade; group 3: patients with previous retinal detachment surgery.
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ocular inflammatory reaction with fast regression after 
removal of Densiron 68 and anti-inflammatory therapy 
(topical steroid application). In 1 eye (group 1) postop-
erative moderate inflammation occurred after traumatic 
retinal detachment and a simultaneous tuberculous in-
fection of the eye; in another eye (group 3), recurrent 
chronic uveitis intermedia was described preoperatively. 
Four of the 5 eyes (80%) that received Densiron 68 twice 
showed moderate (2 eyes) to severe (2 eyes) inflammation 
with the tamponade agent in the vitreous. Compared to 
groups 1 and 3 this proportion of inflammation is sig-
nificantly higher (p  ! 0.005). After removal of Densiron 
68 the inflammatory process completely resolved in these 
eyes. 
 Keratopathy, Hypotony and Cataract Formation 
 With heavy silicone oil in situ, 1 eye developed a total 
corneal decompensation that made a keratoplasty neces-
sary. In this eye a decompensation of IOP during the con-
ventional silicone oil tamponade immediately before 
heavy endotamponade and a preexisting primary open-
angle glaucoma had been described. After removal of 
heavy oil, band keratopathy occurred in 2 cases. In 1 of 
these eyes a keratoplasty had previously been performed. 
In 2 further eyes a total stromal edema coincided with 
phthisis bulbi. Mild to moderate stromal edema occurred 
postoperatively in 12 eyes but resolved within a few weeks. 
Neither silicone oil in the anterior chamber nor the lens 
situation influenced the incidence of keratopathy in our 
study population significantly. Phthisis bulbi was ob-
served solely in group 3 (eyes with former unsuccessful 
retinal surgery) in 7 cases. Six months after Densiron 68 
removal, hypotony was present in 3 eyes.
 In all phakic eyes cataract formation could be observed 
and phacoemulsification was performed if useful. 
 The number and distribution of adverse effects among 
the different groups are shown in  tables 3 and  5 .
 Discussion 
 Complicated retinal detachment is successfully treat-
ed with conventional silicone oil combined with ad-
vanced vitreous surgical techniques. In cases of PVR, the 
anatomic success rate varies between 30 and almost 83% 
 [16] . Nevertheless, the postoperative success is often com-
plicated by persisting or newly developing inferior de-
tachment that often acquires a long-term internal tam-
ponade with silicone oil. The higher specific density of 
Densiron 68 and other heavy silicone oils theoretically 
permits a more effective tamponade of the inferior and 
posterior retinal areas. 
 In our examination retinal reattachment could be 
achieved in 98% after initial surgery. Six months after re-
moval of Densiron 68, an anatomical success rate of 87.6% 
was obtained. Fifty eyes (64%) without any tamponade 
agent in situ showed reattached retinas at the study end 
point. Compared to our recent publication with a reat-
tachment rate of 91.7% (44/48 eyes) 3 months after Den-
siron 68 removal the percentage of reattached retina re-
mains stable  [14] . The ratio of successfully treated eyes 
without persisting endotamponade was even improved. 
Anatomical success was not as high as recently described 
by Wong et al.  [13] . Nevertheless, considering the more 
complicated preoperative conditions of most of our cases, 
the results in this study are satisfying. Wolf et al.  [17] re-
ported similar results in 33 eyes with a comparable retinal 
status at baseline. They used Oxane HD (specific density 
1.03 g/cm 3 ), a solution of polydimethylsiloxane and a 
mixed fluorinated and hydrocarbonated olefin (RMN3) 
as heavy tamponade agent. Twelve months after initial 
surgery the retina was attached in 18 eyes (54%) without 
intraocular tamponade. In 13 further eyes the retina was 
reattached completely with conventional silicone oil in 
situ. In our study most failures were due to reproliferation 
and formation of new retinal breaks. The anatomical re-
sults in eyes with multiple unsuccessful previous opera-
tions (group 3) and in eyes that received Densiron 68 
twice (group 2) are encouraging. 
 In addition, a higher percentage of completely attached 
retinas in eyes with heavy versus conventional silicone oil 
in situ was observed. The better support on the inferior 
retinal areas can be deduced from the location of retinal 
redetachment. Inferior areas are affected in 2 out of 6 
(group 1: 33%) and 8 out of 12 eyes (group 4: 66%), respec-
tively, as shown in  table 4 . 
 In contrast to the results reported by Wong et al.  [13] , 
mean visual acuity did not improve in the entire study 
population. It solely showed a slight increase in groups 1 
and 2. Nonetheless, the higher preoperative mean
logMAR that reflects the worse starting position in our 
study should be considered. After all an improvement of 
2 or more Snellen lines was obtained in 33 eyes (37%). The 
preservation of ambulatory vision could be achieved in 
40 eyes that underwent previously unsuccessful retinal 
surgery. The better visual outcome shortly after surgical 
intervention in patients with standard silicone oil in
situ (although the difference in median postoperative
logMAR is insignificant) should be regarded attentively 
for a longer follow-up time. Possibly the persisting retinal 
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distances lead to further retinal redetachment and resul-
tant visual decrease in eyes with standard silicone oil 
treatment. 
 Most adverse effects such as hypotony, raised IOP and 
bullous or band keratopathy are well-known complica-
tions of standard silicone oil and do not differ clinically 
significantly in number and severity  [1, 16, 18, 19] . De-
spite the fact that the good intraocular tolerance of Den-
siron 68 recently described by Wong et al.  [13] could be 
confirmed in this study by the comparison of the number 
of adverse effects with standard versus heavy silicone oil 
in vitreous in most cases, the tendency towards a more 
frequent moderate intraocular inflammation with Den-
siron 68 in situ should be carefully observed in future 
studies. Because the inflammation rate was extremely 
high in group 2, a second intraocular tamponade with 
Densiron 68 in the same eye should be considered criti-
cally. During and after Densiron endotamponade, a high 
percentage of emulsified oil in the anterior chamber was 
observed as well. One should consider that the largest 
proportion of our study population had been operated 
previously and a high percentage of eyes got its second or 
third endotamponade and had therefore been damaged 
before. This may explain the higher percentage of com-
plications compared to the clinical experiences with stan-
dard silicone oil. Comparing eyes with first endotampon-
ade (groups 1 and 4), a significant difference between 
standard and heavy silicone oil could not be observed 
( table 4 ). These results must be considered carefully be-
cause of the small study population and the retrospective 
character of our control group.
 Clinically significant adverse effects after oil removal 
that seemed to be specific for heavy silicone oil could not 
be ascertained.
 In summary, these results support the hypothesis of 
Densiron 68 as potent tamponade agent for complicated 
retinal detachment in the inferior retinal segments espe-
cially in eyes where a previous operation failed. The clin-
ical relevance of adverse effects has to be evaluated in 
further prospective controlled trials.
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